These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2579731)

  • 1. Depression of the hepatic cytochrome P-450 monooxygenase system by treatment of mice with the antineoplastic agent 5-azacytidine.
    Gooderham NJ; Mannering GJ
    Cancer Res; 1985 Apr; 45(4):1569-72. PubMed ID: 2579731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of muroctasin on the activities of drug metabolizing enzymes in liver microsomes of rats.
    Kamataki T; Komori M; Iwasaki M; Ohi H; Kitada M; Miura T; Ono K
    Arzneimittelforschung; 1988 Jul; 38(7A):1019-22. PubMed ID: 3263867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression of the hepatic cytochrome P-450 mono-oxygenase system by administered tilorone (2,7-bis(2-(diethylamino)ethoxy)fluoren-9-one dihydrochloride).
    Renton KW; Mannering GJ
    Drug Metab Dispos; 1976; 4(3):223-31. PubMed ID: 6226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of hepatic mixed-function oxidase enzymes in mice by acute and chronic treatment with selenium.
    Ishikawa M; Sasaki M; Koiwai K; Ozaki M; Takayanagi Y; Sasaki K
    J Pharmacobiodyn; 1992 Aug; 15(8):377-85. PubMed ID: 1479537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunochemical detection and quantitation of microsomal cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate:cytochrome P-450 reductase in the rat ventral prostate.
    Haaparanta T; Halpert J; Glaumann H; Gustafsson JA
    Cancer Res; 1983 Nov; 43(11):5131-7. PubMed ID: 6413054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary influences on the hepatic mixed-function oxidase system in the rat after portacaval anastomosis.
    Proia AD; Edwards KD; McNamara DJ; Anderson KE
    Gastroenterology; 1984 Apr; 86(4):618-26. PubMed ID: 6698363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition and induction of hepatic drug metabolism in rats and mice by nafimidone and its major metabolite nafimidone alcohol.
    Rush WR; Smith SA; Mulvey JH; Graham DJ; Chaplin MD
    Drug Metab Dispos; 1987; 15(4):571-8. PubMed ID: 2888633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of hepatic drug-metabolizing enzymes by arachidonic acid.
    Pessayre D; Mazel P; Descatoire V; Rogier E; Feldmann G; Benhamou JP
    Xenobiotica; 1979 May; 9(5):301-10. PubMed ID: 115160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic fate of the new anti-ulcer drug enprostil in animals. 4th communication: effect on hepatic drug metabolizing enzyme system in rats.
    Yamada Y; Nakahara M; Kohno M; Otsuka M; Takaiti O
    Arzneimittelforschung; 1989 Mar; 39(3):356-60. PubMed ID: 2502989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of aluminum on the hepatic mixed function oxidase and drug metabolism.
    Bidlack WR; Brown RC; Meskin MS; Lee TC; Klein GL
    Drug Nutr Interact; 1987; 5(1):33-42. PubMed ID: 3105994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of dietary carbohydrates (alpha-saccharides) on hepatic drug metabolism in male rats.
    Sonawane BR; Coates PM; Yaffe SJ; Koldovsky O
    Drug Nutr Interact; 1983; 2(1):7-16. PubMed ID: 6678749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portal vein ligation selectively lowers hepatic cytochrome P450 levels in rats.
    Farrell GC; Zaluzny L
    Gastroenterology; 1983 Aug; 85(2):275-82. PubMed ID: 6862153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketoconazole: a potent inhibitor of cytochrome P-450-dependent drug metabolism in rat liver.
    Sheets JJ; Mason JI
    Drug Metab Dispos; 1984; 12(5):603-6. PubMed ID: 6149911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective effects of mercaptoundecahydrododecaborate (Na2B12H11SH) on the hepatic microsomal mono-oxygenase enzyme system and on hexobarbital induced sleep in mice.
    Fontenelle LJ; Soltani B; Garner G
    Proc West Pharmacol Soc; 1988; 31():153-6. PubMed ID: 3211896
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of model traumatic injury on hepatic drug metabolism in the rat. III. Differential responses of cytochrome P-450 subpopulations.
    Griffeth LK; Rosen GM; Rauckman EJ
    Drug Metab Dispos; 1984; 12(5):588-95. PubMed ID: 6149909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the combined chemotherapeutic drug tuboprim on drug metabolism.
    Mitcheva M; Staneva-Stoytcheva D
    Acta Physiol Pharmacol Bulg; 1988; 14(1):35-41. PubMed ID: 3407414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cold preservation and reperfusion on microsomal cytochrome P-450-linked monooxygenase system of the rat liver.
    Izuishi K; Ichikawa Y; Hossain MA; Maeba T; Maeta H; Tanaka S
    J Surg Res; 1996 Mar; 61(2):361-6. PubMed ID: 8656609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc mediates normalization of hepatic drug metabolizing enzymes in chlorpyrifos-induced toxicity.
    Goel A; Dani V; Dhawan DK
    Toxicol Lett; 2007 Feb; 169(1):26-33. PubMed ID: 17194553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of three recombinant human leukocyte interferons on drug metabolism in mice.
    Parkinson A; Lasker J; Kramer MJ; Huang MT; Thomas PE; Ryan DE; Reik LM; Norman RL; Levin W; Conney AH
    Drug Metab Dispos; 1982; 10(6):579-85. PubMed ID: 6130903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of levels of feed restriction on in vivo and in vitro alterations in drug metabolism and associated enzymes.
    Sachan DS; Su PK
    Drug Nutr Interact; 1986; 4(4):363-70. PubMed ID: 3792217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.